To further determine whether the expression of CSN6 is associated with the prognosis of melanoma patients, survival database analysis of the R2: Genomics Analysis and Visualization Platform was performed and found that high expression of CSN6 was associated with poor overall survival, whereas a low CSN6 level was implicated in prolonged overall survival (Fig. 1E, F). Here, COPS6 is linked to melanoma.